38A-30194-31397 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Dose 1 — Janssen/Johnson & Johnson
2021-03-17
Registered in v-safe
2021-03-17
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-20
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-27
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-04-03
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-04-10
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-06-05
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-09-04
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-03-06
Survey response — 12 months, dose 1
MedDRA: Anosmia, Headache, Nasopharyngitis — Feeling: Good

Free text: Cold-like symptoms, headache, loss of smell

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Janssen/Johnson & Johnson

Free text

Release 11 — 12 months, dose 1

2022-03-06

Symptoms: Cold-like symptoms, headache, loss of smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anosmia	·	·	✓
SD	Headache	·	·	✓
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release